𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection

✍ Scribed by Alexander, G.J.M.; Fagan, E.A.; Guarner, P.; Rolando, N.; Brahm, J.; Eddleston, A.L.W.F.; Williams, R.

Book ID
122366014
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
351 KB
Volume
3
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomised controlled trial of recombi
A randomised controlled trial of recombinant interferon-Ξ³ in chinese patients with chronic hepatitis B virus infection
✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNΞ³) 0.1 mg/m^2^ intramuscularly thrice weekly for

Efficacy and tolerability of interferon
Efficacy and tolerability of interferon (Intron a) plus ribavirin (Rebetron) administered daily for two months, then thrice weekly interferon (Intron a) plus ribavirin (Rebetron), versus standard thrice weekly administration of Rebetron for the treatment of chronic hepatitis C in patients naive to interferon therapy
✍ Michael S. Epstein; Teresa DeHaemer; Patricia M. Praschak; Robert G. Finkel; Nat πŸ“‚ Article πŸ“… 2001 πŸ› Nature Publishing Group 🌐 English βš– 22 KB